Avecho Biotechnology Ltd - ESG Rating & Company Profile powered by AI
The Disclosure rating covers seventeen UN SDGs including: 'No Poverty', 'Climate Action' and 'Life below Water'. Other companies in the rating industry group for Avecho Biotechnology Ltd are shown below. If you are employed by Avecho Biotechnology Ltd and you wish to licence your Sustainability rating, please contact us.
Avecho Biotechnology Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 8.0 and governance score of 2.7.
6.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
427 | Scancell Holdings PLC | 6.3 | High |
427 | Verastem Inc | 6.3 | High |
450 | Avecho Biotechnology Ltd | 6.2 | High |
450 | Cannasouth Ltd | 6.2 | High |
450 | CareDx International AB | 6.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Avecho Biotechnology Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Avecho Biotechnology Ltd disclose current and historical energy intensity?
Does Avecho Biotechnology Ltd report the average age of the workforce?
Does Avecho Biotechnology Ltd reference operational or capital allocation in relation to climate change?
Does Avecho Biotechnology Ltd disclose its ethnicity pay gap?
Does Avecho Biotechnology Ltd disclose cybersecurity risks?
Does Avecho Biotechnology Ltd offer flexible work?
Does Avecho Biotechnology Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Avecho Biotechnology Ltd disclose the number of employees in R&D functions?
Does Avecho Biotechnology Ltd conduct supply chain audits?
Does Avecho Biotechnology Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Avecho Biotechnology Ltd conduct 360 degree staff reviews?
Does Avecho Biotechnology Ltd disclose the individual responsible for D&I?
Does Avecho Biotechnology Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Avecho Biotechnology Ltd disclose current and / or historical scope 2 emissions?
Does Avecho Biotechnology Ltd disclose water use targets?
Does Avecho Biotechnology Ltd have careers partnerships with academic institutions?
Did Avecho Biotechnology Ltd have a product recall in the last two years?
Does Avecho Biotechnology Ltd disclose incidents of discrimination?
Does Avecho Biotechnology Ltd allow for Work Councils/Collective Agreements to be formed?
Has Avecho Biotechnology Ltd issued a profit warning in the past 24 months?
Does Avecho Biotechnology Ltd disclose parental leave metrics?
Does Avecho Biotechnology Ltd disclose climate scenario or pathway analysis?
Does Avecho Biotechnology Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Avecho Biotechnology Ltd disclose the pay ratio of women to men?
Does Avecho Biotechnology Ltd support suppliers with sustainability related research and development?
Does Avecho Biotechnology Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Avecho Biotechnology Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Avecho Biotechnology Ltd involved in embryonic stem cell research?
Does Avecho Biotechnology Ltd disclose GHG and Air Emissions intensity?
Does Avecho Biotechnology Ltd disclose its waste policy?
Does Avecho Biotechnology Ltd report according to TCFD requirements?
Does Avecho Biotechnology Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Avecho Biotechnology Ltd disclose energy use targets?
Does Avecho Biotechnology Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Avecho Biotechnology Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Avecho Biotechnology Ltd
These potential risks are based on the size, segment and geographies of the company.
Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.